• Dr. Jim Newcombe to succeed Dr. Colin Goldschmidt as Managing Director and CEO
• Evangelos Kotsopoulos appointed as Chief Operating Officer of Sonic Healthcare group
• Dr. Goldschmidt to retire after 32 years as CEO, will continue as Advisor to the Sonic Board

Sonic Healthcare Limited (ASX: SHL; ADR: SKHHY) today announces that Managing Director and Chief Executive Officer Dr. Colin Goldschmidt will retire at the company's Annual General Meeting on 20 November 2025, and that Dr. Jim Newcombe will become the new Managing Director and CEO with effect from that date. In addition, Mr. Evangelos Kotsopoulos will be appointed to the newly created position of Chief Operating Officer of the Sonic Healthcare group. Sonic Healthcare Chairman Professor Mark Compton praised Dr. Goldschmidt's leadership over the past 32 years, during which he led Sonic's expansion from a single laboratory in Sydney to become the third largest pathology player in the world. The Board is excited about Dr. Newcombe's passion and strategy for the company, and he, Mr. Kotsopoulos, and the senior executive team will have the Board's full support as they implement prudent change while preserving Sonic's unique culture and values. Dr. Newcombe is a pathologist specialised in clinical microbiology, an infectious diseases physician, and a senior medical leader who has extensive experience in governance, strategy, and quality improvement. Mr. Kotsopoulos is currently the CEO of Sonic Healthcare Europe and Sonic Healthcare Germany, overseeing Sonic's operations in Germany, Switzerland, and Belgium. Following his retirement, Dr. Goldschmidt will be retained as an Advisor to the Sonic Board in a part-time unpaid capacity and will continue to chair the Sonic Healthcare Foundation board.

Sonic Healthcare is well positioned for ongoing growth, with a strong leadership team committed to delivering outstanding value for shareholders through continued improvements in operational efficiency and leveraging Sonic's fine reputation and strong market position.